High osteoprotegerin serum levels in primary biliary cirrhosis are associated with disease severity but not with the mRNA gene expression in liver tissue

Journal of Bone and Mineral Metabolism

Volumn 27, Issue 3, 2009, Pages 347-354

  Guañabens, Núria ^a   Enjuanes, Anna ^a   Alvarez, Luisa ^a   Peris, Pilar ^a   Caballería, Llorenç ^a   Jesus Martinez De Osaba M ^a   Cerdá, Dacia ^a   Monegal, Anna ^a   Pons, Francesca ^a   Parés, Albert ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Bone turnover; Cholestasis; Osteoporosis; RANKL

Indexed keywords

25 HYDROXYVITAMIN D; BILIRUBIN; CALCIUM; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ADULT; ARTICLE; BONE DENSITY; BONE TURNOVER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OSTEOPOROSIS; PATHOGENESIS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BIOLOGICAL MARKERS; BONE REMODELING; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LIVER; LIVER CIRRHOSIS, BILIARY; MIDDLE AGED; OSTEOPROTEGERIN; RANK LIGAND; RNA, MESSENGER;

EID: 64949108079     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-009-0042-1     Document Type: Article

References (31)

1. N Guañabens A Parés L Mariñoso MA Brancós C Piera S Serrano 1990 Factors influencing the development of metabolic bone disease in primary biliary cirrhosis Am J Gastroenterol 85 1356 1361
2. WD Leslie CN Bernstein MS Leboff The American Gastroenterological Association Clinical Practice Committee 2003 AGA Technical Review on Osteoporosis in Hepatic Disorders Gastroenterology 125 941 966
3. SF Hodgson ER Dickson R Eastell EF Eriksen SC Bryant BL Riggs 1993 Rates of cancellous bone remodeling and turnover in osteopenia associated with primary biliary cirrhosis Bone 14 819 827
4. N Guañabens A Parés I Ros L Caballería F Pons S Vidal 2005 Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis J Hepatol 42 573 577
5. WS Simonet DL Lacey CR Dunstan M Kelley MS Chang R Lûthy 1997 Osteoprotegerin: a novel secreted protein involved in the regulation of bone density Cell 89 309 319
6. H Yasuda N Shima N Nakagawa SI Mochizuki K Yano N Fujise 1998 Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro Endocrinology 139 1329 1337
7. S Koshla 2001 Minireview: the OPG/RANKL/RANK System Endocrinology 142 5050 5055
8. S Theoleyre Y Wittrant SK Tat Y Fortun F Redini D Heymann 2004 The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathological bone remodeling Cytokine Growth Factor Rev 15 49 60
9. WJ Boyle WS Simonet DL Lacey 2003 Osteoclast differentiation and activation Nature 423 337 342
10. F Szalay D Hegedus PL Lakatos I Tornai E Bajnook K Dunkel 2003 High serum osteoprotegerin and low RANKL in primary biliary cirrhosis J Hepatol 38 395 400
11. A Gaudio A Lasco N Morabito M Atteritano C Vergara A Catalano 2005 Hepatic osteodystrophy: does the osteoprotegerin/receptor activator of nuclear factor-κB ligand system play a role J Endocrinol Invest 28 677 682
12. AR Moschen A Kaser S Stadlmann G Millonig S Kaser P Mühllechner 2005 The RANKL/OPG system and bone mineral density in patients with chronic liver disease J Hepatol 43 973 983
13. J Ludwig ER Dickson GSA McDonald 1978 Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis) Virchows Arch (Pathol Anat) 379 103 112
14. WHO Study Group 1994 Assessment of fracture risk and its application to screening for postmenopausal osteoporosis World Health Organ Tech Rep Ser 843 1 129
15. K Yano E Tsuda N Washida F Kobayashi M Goto A Harada 1999 Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis J Bone Miner Res 14 518 527
16. A Rogers G Saleh RA Hannon D Greenfield R Eastell 2002 Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women J Clin Endocrinol Metab 87 4470 4475
17. WS Browner LY Lui SR Cummings 2001 Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women J Clin Endocrinol Metab 86 631 637
18. P Szulc LC Hofbauer AE Heufelder S Roth PD Delmas 2001 Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone status J Clin Endocrinol Metab 86 3162 3165
19. D Hegedus V Fernencz PL Lakatos S Meszaros P Lakatos C Horvath 2002 Decreased bone density, elevated serum osteoprotegerin, and β-Cross-Laps in Wilson disease J Bone Miner Res 17 1961 1967
20. JL Gonzalez-Calvin JL Mundi FJ Casado EG Olivares 2004 Bone mineral density and serum levels of estradiol and osteoprotegerin in postmenopausal women with viral cirrhosis Gastroenterology 126 1225 1226
21. E Fábrega A Orive C García-Suárez M García-Unzueta A Amado F Pons-Romero 2005 Osteoprotegerin and RANKL in alcoholic liver cirrhosis Liver Int 25 305 310
22. A Monegal N Guañabens M Navasa L Alvarez D Ozalla P Peris 2007 Serum osteoprotegerin and its ligand in cirrhotic patients referred for orthotopic liver transplantation: relationship with metabolic bone disease J Liver Int 27 492 497
23. E García-Valdecasas-Campelo E González-Reimers F Santolaria-Fernández MJ De la Vega-Prieto A Milena-Abril MJ Sánchez-Pérez 2006 Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease Alcohol Alcohol 41 261 266
24. L Alvarez P Peris N Guañabens S Vidal I Ros F Pons 2003 Serum osteoprotegerin and its ligand in Paget's disease of bone. Relationship to disease activity and effect of treatment with bisphosphonates Arthritis Rheum 48 824 828
25. LC Hofbauer M Schoppet 2004 Clinical implications of the Osteoprotegerin/RANKL/RANK system for bone and vascular diseases JAMA 292 490 495
26. T Nagano K Yamamoto S Matsumoto R Okamoto M Tagashira N Ibuki S Matsumura K Yabushita N Okano T Tsuji 1999 Cytokine profile in the liver of primary biliary cirrhosis J Clin Immunol 19 422 427
27. M Neuman P Angulo I Malkiewicz R Jorgensen N Shear ER Dickson J Harver G Katz K Lindor 2002 Tumor necrosis factor alpha and transforming growth factor beta reflect severity of liver damage in primary biliary cirrhosis J Gastroenterol Hepatol 17 196 202
28. LC Hofbauer S Koshla CR Dunstan DL Lacey WJ Boyle BL Riggs 2000 The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption J Bone Miner Res 15 2 12
29. B Bolon V Shalhoub PJ Kostenuik G Campagnuolo S Morony WJ Boyle 2002 Osteoprotegerin, an endogenous antiosteoclast factor for protecting bone in rheumatoid arthritis Arthritis Rheum 46 3121 3135
30. AJ Stellon A Webb J Compston R Williams 1987 Low bone turnover state in primary biliary cirrhosis Hepatology 7 137 147
31. Schett G, Kiechl S, Redlich K, Oberhollenzer F, Weger S, Egger G et al (2004) Soluble RANKL and risk of nontraumatic fracture. JAMA 291:1108-1113